pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

pharmaphorum

DECEMBER 21, 2021

In a recent webinar held by pharmaphorum, in partnership with IQVIA, a discussion was held looking at how to make academic and commercial medical research more efficient, while also looking at the opportunity of genomic data to bring benefits to patients and healthcare systems. The potential to leverage genomic data.

Development 96

Development Genome Genomics Drugs 96

pharmaphorum

JANUARY 29, 2021

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Sangamo CEO Sandy Macrae told us how his company is being cautious about the hype and finding ways to be financially viable in an emerging space. The genomic medicine journey.

Gene Editing 144

Gene Editing Gene Gene Therapy In-Vivo 144

pharmaphorum

JANUARY 24, 2022

That is backed up by a meta analysis of its performance published last year in Nature found that the treatment recommendations delivered by the tool were largely in line with human doctors for several cancer types.

Radiology 111

Radiology Marketing Genome Genomics 111

pharmaphorum

OCTOBER 5, 2021

The time of individuals relying entirely on face-to-face interaction with their doctors is long past. Although junior doctors may be more digitally native, it is possible that there will be more widespread adoption in experienced medical professionals, because they understand the medical and patient end value better.

Doctors 129

Doctors Doctor Marketing Development 129

XTalks

OCTOBER 15, 2021

This included segregated wards at Johns Hopkins containing Black patients with cervical cancer whom white doctors would collect samples from without their knowledge or consent. However, the agreement did not include a share of any profits that researchers or pharma companies may make from use of the cells.

Vaccination 105

Vaccination Vaccine Gene Mapping Doctors 105

pharmaphorum

AUGUST 9, 2022

The potential of the area has motivated an increasing number of companies to emerge in the space, with a greater number of collaborations occurring between these AI-specialists and big pharma companies. Patient focus.

Drugs 105

Drugs Doctors Doctor Pharma Companies 105